OpenVSafe by OpenVAERS
Search V-safe

2CQ-21472-80959

2 vaccinations 11 coded responses 30 check-ins 11 free-text entries 8 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
973 / OR
Registered
2021-04-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1400389 (opens in a new window) high 8 / 11 4 4 of 12 VAERS symptoms VAERS dose unknown OR matches 2021-04-08 / 2021-04-12 / 2021-06-15
received 47 days after the last call
case 611149

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-04-08
    Registered in v-safe
  2. 2021-04-08
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-08
    Health check-in — day 0, dose 1
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  4. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Nausea
    Adult check-in
  6. 2021-04-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Ear discomfort, Sinus disorder — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Free text: Congestion in ears and sinuses
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Heart rate increased, Hypoaesthesia, Hypoaesthesia oral, Speech disorder developmental — Feeling: Poor · Site: Pain, Itching · Headache, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Tongue, lip, face numbness, accelerated heart rate, cognitive lag in speech
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-12
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Itching · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Adult check-in
  10. 2021-04-13
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  11. 2021-04-14
    Survey response — days 1–6 daily, dose 1
    MedDRA: Office visit, Pain in extremity — Feeling: Fair · Fever · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Systemic reaction (other): Leg pain · Healthcare visit (other): Behavioral Health Consultation about medical trauma
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-04-14
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-04-15
    Survey response — day 7, dose 1
    MedDRA: Muscle spasms, Pain in extremity — Feeling: Fair · Headache, Muscle or body aches · Be unable to work, Be unable to do your normal daily activities
    Free text: Leg pain and cramps
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-24
    Health check-in — day 14, dose 1
    Feeling: Poor
    Adult check-in
  15. 2021-04-29
    Survey response — day 21, single dose
    MedDRA: Dizziness, Headache, Visual impairment — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Severe persistent headache, vision change, dizziness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-29
    Report sent to call center — day 21, single dose
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-05-06
    Health check-in — day 28, single dose
    Feeling: Fair
    Adult check-in
  18. 2021-05-13
    Survey response — day 35, single dose
    MedDRA: Mass — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Lump in leg
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-05-13
    Report sent to call center — day 35, single dose
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-05-20
    Health check-in — day 42, single dose
    Feeling: Fair
    Adult check-in
  21. 2021-06-10
  22. 2021-06-15
    Call successful
    Completed over the phone
  23. 2021-07-10
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  24. 2021-10-07
    Health check-in — 6 months, dose 1
    Feeling: Good
    Adult check-in
  25. 2021-12-04
    Dose 2 — Pfizer-BioNTech
  26. 2021-12-04
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  27. 2021-12-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  28. 2021-12-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Muscle or body aches, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  29. 2021-12-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  30. 2021-12-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Respiratory tract congestion — Feeling: Fair
    Free text: Stuffy and swollen lymph's in neck
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-12-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Nausea
    Adult check-in
  32. 2021-12-11
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  33. 2021-12-18
    Survey response — day 14, dose 2
    MedDRA: Cough, Dyspnoea, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Lung shortness of breath and cough
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-12-25
    Survey response — day 21, dose 2
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Covid 19
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-12-25
    Report sent to call center — day 21, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  36. 2021-12-28
    Call successful
    Completed over the phone
  37. 2022-01-03
    Survey response — day 28, dose 2
    MedDRA: Costochondritis, Dyspnoea, Fatigue, Headache, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Costochondritis, shortness of breath, fatigue, headache, body pain
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-01-03
    Report sent to call center — day 28, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · 1 call case(s)
  39. 2022-01-08
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  40. 2022-01-15
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  41. 2022-03-07
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  42. 2022-06-04
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  43. 2022-12-04
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Viral infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Had a bad bug, not sure if it was Covid (didn't show up on tests) but symptoms were similar
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-12-04
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  45. 2022-12-05

Vaccinations

DoseDateManufacturerCo-administered
12021-04-08Janssen/Johnson & Johnson
22021-12-04Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-04-12 Successful Completed over the phone
2021-04-13 Successful Completed over the phone
2021-04-14 Successful Completed over the phone
2021-04-29 Successful Completed over the phone
2021-05-13 Successful
2021-06-15
Completed over the phone
2021-12-25 Successful
2021-12-28
Completed over the phone
2022-01-03 Successful Completed over the phone
2022-12-04 Unsuccessful Reported to VAERS during previous contact from GDIT

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-11

Systemic reaction (other): Congestion in ears and sinuses

2021-04-12

Systemic reaction (other): Tongue, lip, face numbness, accelerated heart rate, cognitive lag in speech

2021-04-14

Systemic reaction (other): Leg pain
Healthcare visit (other): Behavioral Health Consultation about medical trauma

Release 7 — day 7, dose 1

2021-04-15

Systemic reaction (other): Leg pain and cramps

Release 8 — day 21, single dose

2021-04-29

Symptoms: Severe persistent headache, vision change, dizziness.

Release 8 — day 35, single dose

2021-05-13

Symptoms: Lump in leg

Release 10 — days 1–6 daily, dose 2

2021-12-09

Systemic reaction (other): Stuffy and swollen lymph's in neck

Release 10 — day 14, dose 2

2021-12-18

Symptoms: Lung shortness of breath and cough

Release 10 — day 21, dose 2

2021-12-25

Symptoms: Covid 19

Release 10 — day 28, dose 2

2022-01-03

Symptoms: Costochondritis, shortness of breath, fatigue, headache, body pain

Release 12 — 12 months, dose 2

2022-12-04

Symptoms: Had a bad bug, not sure if it was Covid (didn't show up on tests) but symptoms were similar

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDCostochondritis · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDizziness ✓ ✓ ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDHeadache ✓ ✓ ✓
SDMass ✓ ✓ ✓
SDPain · · ✓
SDUnevaluable event · · ✓
SDViral infection · · ✓
SDVisual impairment ✓ ✓ ✓
SROEar discomfort ✓ ✓ ✓
SROHeart rate increased ✓ ✓ ✓
SROHypoaesthesia ✓ ✓ ✓
SROHypoaesthesia oral ✓ ✓ ✓
SROLymphadenopathy · · ✓
SROMuscle spasms ✓ ✓ ✓
SROPain in extremity ✓ ✓ ✓
SRORespiratory tract congestion · · ✓
SROSinus disorder ✓ ✓ ✓
SROSpeech disorder developmental ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release